mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
pac-1 |
GDSC1000 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
KIN001-236 |
GDSC1000 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
KIN001-260 |
GDSC1000 |
pan-cancer |
AAC |
-0.032 |
0.3 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
MI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
OSI-930 |
GDSC1000 |
pan-cancer |
AAC |
0.035 |
0.3 |